Unveiled: A New Enforcement Method In GSK Settlement
GlaxoSmithKline's recent agreement to plead guilty and pay $3 billion to resolve its liability for the unlawful promotion of certain prescription drugs has been touted by the U.S. Department of Justice...To view the full article, register now.
Already a subscriber? Click here to view full article